APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pathology Image Analysis Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathology Image Analysis Software Market Outlook and Growth Opportunities 2026

1 May 2026198 pages

Choose your research edition.

Industry ResearchPathology Image Analysis Software Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathology Image Analysis Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pathology Image Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathology Image Analysis Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathology Image Analysis Software Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global Pathology Image Analysis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pathology Image Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pathology Image Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pathology Image Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pathology Image Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pathology Image Analysis Software market include Aiforia, Visiopharm, Indica Labs, BMD Software, Biocellvia, HeteroGenius, MLM Medical Labs, Sectra and Augmentiqs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pathology Image Analysis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathology Image Analysis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathology Image Analysis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathology Image Analysis Software market.

Pathology Image Analysis Software Segment by Company

Aiforia

Visiopharm

Indica Labs

BMD Software

Biocellvia

HeteroGenius

MLM Medical Labs

Sectra

Augmentiqs

3DHISTECH Ltd.

Gestalt

KFBIO

Proscia

Pathology Image Analysis Software Segment by Type

On-premise

Cloud Based

Pathology Image Analysis Software Segment by Application

Pathological Diagnosis

Clinical Laboratory

Drug Discovery

Others

Pathology Image Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathology Image Analysis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathology Image Analysis Software key companies, revenue, market share, and recent developments.

3. To split the Pathology Image Analysis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathology Image Analysis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathology Image Analysis Software significant trends, drivers, influence factors in global and regions.

6. To analyze Pathology Image Analysis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Image Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Image Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Image Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathology Image Analysis Software industry.

Chapter 3: Detailed analysis of Pathology Image Analysis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathology Image Analysis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathology Image Analysis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathology Image Analysis Software Industry Trends Table 2. Pathology Image Analysis Software Industry Drivers Table 3. Pathology Image Analysis Software Industry Opportunities and Challenges Table 4. Pathology Image Analysis Software Industry Restraints Table 5. Global Pathology Image Analysis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathology Image Analysis Software Revenue Share by Company (2021-2026) Table 7. Global Pathology Image Analysis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathology Image Analysis Software Key Company Manufacturing Base & Headquarters Table 9. Global Pathology Image Analysis Software Company, Product Type & Application Table 10. Global Pathology Image Analysis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathology Image Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-premise Table 15. Significant Companies of Cloud Based Table 16. Global Pathology Image Analysis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pathology Image Analysis Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pathology Image Analysis Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pathology Image Analysis Software Sales Value Share by Type (2021-2026) Table 20. Global Pathology Image Analysis Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pathological Diagnosis Table 22. Significant Companies of Clinical Laboratory Table 23. Significant Companies of Drug Discovery Table 24. Significant Companies of Others Table 25. Global Pathology Image Analysis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pathology Image Analysis Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pathology Image Analysis Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pathology Image Analysis Software Sales Value Share by Application (2021-2026) Table 29. Global Pathology Image Analysis Software Sales Value Share by Application (2027-2032) Table 30. Global Pathology Image Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pathology Image Analysis Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pathology Image Analysis Software Sales Value Share by Region (2021-2026) Table 33. Global Pathology Image Analysis Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pathology Image Analysis Software Sales Value Share by Region (2027-2032) Table 35. Global Pathology Image Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pathology Image Analysis Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pathology Image Analysis Software Sales Value Market Share by Country (2021-2026) Table 38. Global Pathology Image Analysis Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pathology Image Analysis Software Sales Value Market Share by Country (2027-2032) Table 40. Aiforia Company Information Table 41. Aiforia Business Overview Table 42. Aiforia Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Aiforia Pathology Image Analysis Software Product Portfolio Table 44. Aiforia Recent Development Table 45. Visiopharm Company Information Table 46. Visiopharm Business Overview Table 47. Visiopharm Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Visiopharm Pathology Image Analysis Software Product Portfolio Table 49. Visiopharm Recent Development Table 50. Indica Labs Company Information Table 51. Indica Labs Business Overview Table 52. Indica Labs Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Indica Labs Pathology Image Analysis Software Product Portfolio Table 54. Indica Labs Recent Development Table 55. BMD Software Company Information Table 56. BMD Software Business Overview Table 57. BMD Software Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. BMD Software Pathology Image Analysis Software Product Portfolio Table 59. BMD Software Recent Development Table 60. Biocellvia Company Information Table 61. Biocellvia Business Overview Table 62. Biocellvia Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Biocellvia Pathology Image Analysis Software Product Portfolio Table 64. Biocellvia Recent Development Table 65. HeteroGenius Company Information Table 66. HeteroGenius Business Overview Table 67. HeteroGenius Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. HeteroGenius Pathology Image Analysis Software Product Portfolio Table 69. HeteroGenius Recent Development Table 70. MLM Medical Labs Company Information Table 71. MLM Medical Labs Business Overview Table 72. MLM Medical Labs Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. MLM Medical Labs Pathology Image Analysis Software Product Portfolio Table 74. MLM Medical Labs Recent Development Table 75. Sectra Company Information Table 76. Sectra Business Overview Table 77. Sectra Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sectra Pathology Image Analysis Software Product Portfolio Table 79. Sectra Recent Development Table 80. Augmentiqs Company Information Table 81. Augmentiqs Business Overview Table 82. Augmentiqs Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Augmentiqs Pathology Image Analysis Software Product Portfolio Table 84. Augmentiqs Recent Development Table 85. 3DHISTECH Ltd. Company Information Table 86. 3DHISTECH Ltd. Business Overview Table 87. 3DHISTECH Ltd. Pathology Image Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. 3DHISTECH Ltd. Pathology Image Analysis Software Product Portfolio Table 89. 3DHISTECH Ltd. Recent Development Table 90. Gestalt Company Information Table 91. Gestalt Business Overview Table 92. Gestalt Pathology Image Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Gestalt Pathology Image Analysis Software Product Portfolio Table 94. Gestalt Recent Development Table 95. KFBIO Company Information Table 96. KFBIO Business Overview Table 97. KFBIO Pathology Image Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. KFBIO Pathology Image Analysis Software Product Portfolio Table 99. KFBIO Recent Development Table 100. Proscia Company Information Table 101. Proscia Business Overview Table 102. Proscia Pathology Image Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Proscia Pathology Image Analysis Software Product Portfolio Table 104. Proscia Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Pathology Image Analysis Software Product Image Figure 2. Global Pathology Image Analysis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Image Analysis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathology Image Analysis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-premise Image Figure 8. Cloud Based Image Figure 9. Global Pathology Image Analysis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pathology Image Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pathology Image Analysis Software Sales Value Share by Type (2021-2032) Figure 12. Pathological Diagnosis Image Figure 13. Clinical Laboratory Image Figure 14. Drug Discovery Image Figure 15. Others Image Figure 16. Global Pathology Image Analysis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pathology Image Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pathology Image Analysis Software Sales Value Share by Application (2021-2032) Figure 19. Global Pathology Image Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pathology Image Analysis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pathology Image Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pathology Image Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pathology Image Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pathology Image Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pathology Image Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pathology Image Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pathology Image Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pathology Image Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pathology Image Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pathology Image Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pathology Image Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • On-premise
  • Cloud Based
Applications
  • Pathological Diagnosis
  • Clinical Laboratory
  • Drug Discovery
  • Others
Companies covered
  • Aiforia
  • Visiopharm
  • Indica Labs
  • BMD Software
  • Biocellvia
  • HeteroGenius
  • MLM Medical Labs
  • Sectra
  • Augmentiqs
  • 3DHISTECH Ltd.
  • Gestalt
  • KFBIO
  • Proscia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathology Image Analysis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathology Image Analysis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathology Image Analysis Software Market Dynamics
  1. 2.1 Pathology Image Analysis Software Industry Trends
  2. 2.2 Pathology Image Analysis Software Industry Drivers
  3. 2.3 Pathology Image Analysis Software Industry Opportunities and Challenges
  4. 2.4 Pathology Image Analysis Software Industry Restraints
3 Pathology Image Analysis Software Market by Company
  1. 3.1 Global Pathology Image Analysis Software Company Revenue Ranking in 2025
  2. 3.2 Global Pathology Image Analysis Software Revenue by Company (2021-2026)
  3. 3.3 Global Pathology Image Analysis Software Company Ranking (2024-2026)
  4. 3.4 Global Pathology Image Analysis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathology Image Analysis Software Company Product Type and Application
  6. 3.6 Global Pathology Image Analysis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathology Image Analysis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathology Image Analysis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathology Image Analysis Software Market by Type
  1. 4.1 Pathology Image Analysis Software Type Introduction
  2. 4.1.1 On-premise
  3. 4.1.2 Cloud Based
  4. 4.2 Global Pathology Image Analysis Software Sales Value by Type
  5. 4.2.1 Global Pathology Image Analysis Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pathology Image Analysis Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pathology Image Analysis Software Sales Value Share by Type (2021-2032)
5 Pathology Image Analysis Software Market by Application
  1. 5.1 Pathology Image Analysis Software Application Introduction
  2. 5.1.1 Pathological Diagnosis
  3. 5.1.2 Clinical Laboratory
  4. 5.1.3 Drug Discovery
  5. 5.1.4 Others
  6. 5.2 Global Pathology Image Analysis Software Sales Value by Application
  7. 5.2.1 Global Pathology Image Analysis Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pathology Image Analysis Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pathology Image Analysis Software Sales Value Share by Application (2021-2032)
6 Pathology Image Analysis Software Regional Value Analysis
  1. 6.1 Global Pathology Image Analysis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathology Image Analysis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathology Image Analysis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathology Image Analysis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathology Image Analysis Software Sales Value (2021-2032)
  7. 6.3.2 North America Pathology Image Analysis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathology Image Analysis Software Sales Value (2021-2032)
  10. 6.4.2 Europe Pathology Image Analysis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathology Image Analysis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathology Image Analysis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathology Image Analysis Software Sales Value (2021-2032)
  16. 6.6.2 South America Pathology Image Analysis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathology Image Analysis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathology Image Analysis Software Sales Value Share by Country, 2025 VS 2032
7 Pathology Image Analysis Software Country-level Value Analysis
  1. 7.1 Global Pathology Image Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathology Image Analysis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathology Image Analysis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathology Image Analysis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathology Image Analysis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathology Image Analysis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathology Image Analysis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aiforia
  2. 8.1.1 Aiforia Company Information
  3. 8.1.2 Aiforia Business Overview
  4. 8.1.3 Aiforia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aiforia Pathology Image Analysis Software Product Portfolio
  6. 8.1.5 Aiforia Recent Developments
  7. 8.2 Visiopharm
  8. 8.2.1 Visiopharm Company Information
  9. 8.2.2 Visiopharm Business Overview
  10. 8.2.3 Visiopharm Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Visiopharm Pathology Image Analysis Software Product Portfolio
  12. 8.2.5 Visiopharm Recent Developments
  13. 8.3 Indica Labs
  14. 8.3.1 Indica Labs Company Information
  15. 8.3.2 Indica Labs Business Overview
  16. 8.3.3 Indica Labs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Indica Labs Pathology Image Analysis Software Product Portfolio
  18. 8.3.5 Indica Labs Recent Developments
  19. 8.4 BMD Software
  20. 8.4.1 BMD Software Company Information
  21. 8.4.2 BMD Software Business Overview
  22. 8.4.3 BMD Software Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BMD Software Pathology Image Analysis Software Product Portfolio
  24. 8.4.5 BMD Software Recent Developments
  25. 8.5 Biocellvia
  26. 8.5.1 Biocellvia Company Information
  27. 8.5.2 Biocellvia Business Overview
  28. 8.5.3 Biocellvia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Biocellvia Pathology Image Analysis Software Product Portfolio
  30. 8.5.5 Biocellvia Recent Developments
  31. 8.6 HeteroGenius
  32. 8.6.1 HeteroGenius Company Information
  33. 8.6.2 HeteroGenius Business Overview
  34. 8.6.3 HeteroGenius Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HeteroGenius Pathology Image Analysis Software Product Portfolio
  36. 8.6.5 HeteroGenius Recent Developments
  37. 8.7 MLM Medical Labs
  38. 8.7.1 MLM Medical Labs Company Information
  39. 8.7.2 MLM Medical Labs Business Overview
  40. 8.7.3 MLM Medical Labs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MLM Medical Labs Pathology Image Analysis Software Product Portfolio
  42. 8.7.5 MLM Medical Labs Recent Developments
  43. 8.8 Sectra
  44. 8.8.1 Sectra Company Information
  45. 8.8.2 Sectra Business Overview
  46. 8.8.3 Sectra Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sectra Pathology Image Analysis Software Product Portfolio
  48. 8.8.5 Sectra Recent Developments
  49. 8.9 Augmentiqs
  50. 8.9.1 Augmentiqs Company Information
  51. 8.9.2 Augmentiqs Business Overview
  52. 8.9.3 Augmentiqs Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Augmentiqs Pathology Image Analysis Software Product Portfolio
  54. 8.9.5 Augmentiqs Recent Developments
  55. 8.10 3DHISTECH Ltd.
  56. 8.10.1 3DHISTECH Ltd. Company Information
  57. 8.10.2 3DHISTECH Ltd. Business Overview
  58. 8.10.3 3DHISTECH Ltd. Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 3DHISTECH Ltd. Pathology Image Analysis Software Product Portfolio
  60. 8.10.5 3DHISTECH Ltd. Recent Developments
  61. 8.11 Gestalt
  62. 8.11.1 Gestalt Company Information
  63. 8.11.2 Gestalt Business Overview
  64. 8.11.3 Gestalt Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gestalt Pathology Image Analysis Software Product Portfolio
  66. 8.11.5 Gestalt Recent Developments
  67. 8.12 KFBIO
  68. 8.12.1 KFBIO Company Information
  69. 8.12.2 KFBIO Business Overview
  70. 8.12.3 KFBIO Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KFBIO Pathology Image Analysis Software Product Portfolio
  72. 8.12.5 KFBIO Recent Developments
  73. 8.13 Proscia
  74. 8.13.1 Proscia Company Information
  75. 8.13.2 Proscia Business Overview
  76. 8.13.3 Proscia Pathology Image Analysis Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Proscia Pathology Image Analysis Software Product Portfolio
  78. 8.13.5 Proscia Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst